SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 18.85
0.00 (0.00%)
Sep 14, 2026, 1:33 PM CST
TPEX:4192 Market Cap
TPEX:4192 has a market cap or net worth of 662.86 million as of September 15, 2026. Its market cap has decreased by -30.44% in one year.
Market Cap
662.86M
Enterprise Value
529.58M
Revenue
26.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.85
ChartMarket Cap Chart
Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 662.86M, a decrease of -82.07%. That is a compound annual growth rate of -12.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 662.86M | -24.30% |
| Dec 31, 2025 | 875.60M | -28.55% |
| Dec 31, 2024 | 1.23B | -9.24% |
| Dec 29, 2023 | 1.35B | -53.80% |
| Dec 30, 2022 | 2.92B | -20.00% |
| Dec 30, 2021 | 3.65B | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neith | 793.51M |
| TCI GENE | 768.22M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 711.93M |
| Taiwan Advance Bio-Pharmaceutical | 644.40M |
| Bio Preventive Medicine | 628.62M |
| Enimmune | 612.00M |
| Lukas Biomedical | 601.60M |